We Will Be Attending AACR 2023 in Orlando!
American Association for Cancer Research (AACR) annual conference, one of the most anticipated events, is around the corner! We are delighted to announce our upcoming exhibition at this high-profile event in Orlando. As a one-stop shop for animal modeling services, we are ready to discuss with you over innovative strategies applied to cancer research and development of immunotherapy.
Join us to learn more about our immune checkpoint-humanized mice, cytokine receptor-humanized mice, NMG immunodeficient mice and custom genetically engineered mice for studies of cancer. We are looking forward to seeing you at our booth#572. To learn more about AACR 2023.
By the way, don't forget to visit our posters which present our representative humanized mouse models for cancer research. The themes are displayed as follows for your reference. We are expecting your visit.
Poster #5535: Non-IL-2 Blocking Treg-depleting Anti-human CD25 mAb Primes Potent Anti-tumor Immunity and Synergizes Anti-tumor Effects of Anti-PD-1 in a Novel hIL-2RA Knock-in Model
Poster #3198: Anti-angiogenic mAb, Anti-human VEGFR2 (Cyramza) Retards Tumor Growth in KDR (VEGFR2) Humanized Mice Grafted with Syngeneic vs. Xenograft Solid Tumors
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more